BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6651583)

  • 1. Complement metabolism during membrane plasma separation.
    McLeod BC; Viernes A; Sassetti RJ
    Artif Organs; 1983 Nov; 7(4):443-9. PubMed ID: 6651583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation by plasma separator membranes.
    McLeod BC; Viernes A; Sassetti RJ
    Transfusion; 1983; 23(2):143-7. PubMed ID: 6836694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anticoagulant on biocompatibility in membrane plasmapheresis.
    Omokawa S; Malchesky PS; Yamashita M; Suzuki T; Goldcamp JG; Murabayashi S; Nosè Y
    Int J Artif Organs; 1990 Nov; 13(11):768-77. PubMed ID: 2089015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant and membrane effects on humoral and cellular changes during plasmapheresis.
    Omokawa S; Malchesky PS; Yamashita M; Goldcamp JB; Nosé Y
    ASAIO Trans; 1988; 34(3):404-9. PubMed ID: 3264174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of four plasmapheresis membranes in patients treated for hypercholesterolemia.
    Böhler J; Donauer K; Köster W; Schollmeyer PJ; Wieland H; Hörl WH
    Am J Nephrol; 1991; 11(6):479-85. PubMed ID: 1819214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility of different hemodialysis and plasmapheresis membranes.
    Jørstad S
    Blood Purif; 1987; 5(2-3):123-37. PubMed ID: 3497645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of a polyethersulfone hollow fiber plasma separator by animal experiment.
    Zhao CS; Liu T; Lu ZP; Cheng LP; Huang J
    Artif Organs; 2001 Jan; 25(1):60-3. PubMed ID: 11167562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.
    Wiegmann TB; MacDougall ML; Diederich DA
    Am J Kidney Dis; 1988 May; 11(5):418-24. PubMed ID: 3259402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes.
    Stannat S; Bahlmann J; Kiessling D; Koch KM; Deicher H; Peter HH
    Contrib Nephrol; 1985; 46():102-8. PubMed ID: 3874042
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-centrifugal plasma collection using cross-flow membrane plasmapheresis.
    Heal JM; Bailey G; Helphingstine C; Thiem PA; Leddy JP; Buchholz DH; Nusbacher J
    Vox Sang; 1983 Mar; 44(3):156-66. PubMed ID: 6837008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility testing of membrane plasmapheresis devices.
    Lobdell DD
    Life Support Syst; 1987; 5(4):367-72. PubMed ID: 3501506
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma separator Plasmaflo OP.
    Hirata N; Shizume Y; Shirokaze J; Suemitsu J; Yoshida H; Yamawaki N
    Ther Apher Dial; 2003 Feb; 7(1):64-8. PubMed ID: 12921117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the complement C3 fragments associated with hemodialysis membranes.
    Cheung AK; Parker CJ; Janatova J
    Kidney Int; 1989 Feb; 35(2):576-88. PubMed ID: 2785224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
    Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
    Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood flow dependent granulocyte activation in membranes with and without complement activation.
    Böhler J; Donauer J; Schollmeyer P; Hörl WH
    Adv Exp Med Biol; 1991; 297():215-24. PubMed ID: 1767753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of membranes for plasmapheresis.
    Friedman LI; Hardwick RA; Daniels JR; Stromberg RR; Ciarkowski AA
    Artif Organs; 1983 Nov; 7(4):435-42. PubMed ID: 6651582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.